AI-Driven Cross-Border Healthcare Innovation Platform
The New Paradigm to Bridge the World
$197B in cross-border deals last year. Half of big pharma and MedTech pipelines now start in a startup lab. We connect the two — pre-screened, pre-matched, pre-valued — before the first handshake.
- $500B+
- Global ecosystem waiting to connect
- $197B
- Cross-border out-licensing value in 2025
- 50%
- Of big pharma & MedTech pipelines from startups
- 8–12x
- Faster time-to-deal with AI pre-match
The missing layer
The Deals Exist. The Platform Doesn't.
The market doesn't lack breakthroughs, and it doesn't lack buyers. It lacks a structured, AI-powered platform that pre-screens, pre-matches, and pre-values — before the first handshake.
Startup Innovators — Stranded
- World-class science from China, USA, Europe, India, Korea, Japan, Israel — and more: biotech, MedTech, diagnostics, digital health
- No structured pathway to the MNC partners who need it
- No BD infrastructure, no cross-border valuation framework
- Compliance surprises that surface late in diligence — and kill deals
MNC BD Teams — Flying Blind
- You need curated, pre-validated, compliance-cleared early-stage assets — across every sector
- Instead: ad-hoc leads, conference noise, and cold intros
- 12-month diligence black holes that swallow good deals
- 50% of your pipeline is now external — and competitors move first
Efficiently speed up and maximize effective healthcare innovation to enhance life quality globally — by removing every barrier between a breakthrough idea and the patients who need it.
What the platform is made of
One Platform. Six Pillars. Every Healthcare Sector.
Biotech & Pharma · MedTech & Devices · Diagnostics & IVD · Digital Health & AI · Consumer Healthcare · Life Sciences Tools · Cell & Gene Therapy · Surgical Robotics — one structured pathway from first contact to closed deal.
Summits & Events
The annual global Summit · GHIS 2026 Hong Kong · the China roadshow · CPIC · SAPA — the rooms where cross-border deals begin.
For the entire ecosystemSite Immersion Programs
3–5 day curated delegations, in both directions: US hubs from RTP, Boston, and the Bay Area to DC and NY–NJ; Asia hubs in Shanghai, Beijing, and Suzhou.
For startups & MNC teamsAdvisory Services
FDA and IND pathway, IP strategy, CFIUS/BIS/NMPA regulatory navigation, term-sheet support, NewCo formation, and the US payer landscape.
For startupsBD & Deal Facilitation
Out-licensing to 3–5 matched MNC partners, co-development structuring, success fee plus 5–10% upside. We close deals, not meetings.
For MNC BD teamsInnovation Radar
Powered by the Innovation Assets Database (IAD): 300+ assets pre-screened, scored, and matched — partners preview every listing 30 days early, on a SaaS membership.
For MNC BD & investorsStrategic Investment
Angel co-investment, milestone-tranche structures, and a CFIUS-compliant US vehicle — carried interest plus equity upside.
For investorsBuilt to be trusted
How it works
The Deal Flywheel
Source → Validate → Match → Fund → Close → Expand. Six stages, one compounding loop — every closed deal makes the next one faster.
Source
The IAD scans global pipelines. Startups are discovered — or apply directly — and every asset is AI-qualified before human review.
Validate
Deep diligence across science, IP, regulatory, and compliance. A pre-valuation report is built, and compliance is pre-cleared before any MNC contact.
Match
The AI identifies 3–5 ideal MNC partners worldwide. 1:1 meetings are pre-scheduled, with cross-border BD facilitation at the table.
Fund
Co-investment through the angel bridge, milestone-tranche convertible notes, and syndicated VC co-invest.
Close
Term sheet → LOI → signed. Success fee plus equity stake, NewCo formation, and post-deal integration.
Expand
Published case studies attract the next cohort. The network effect compounds with every closed deal.
The engine under the Radar
Pre-Screen · Pre-Match · Pre-Value
The Innovation Radar runs on the Innovation Assets Database (IAD) — every asset screened, scored, and matched by AI before the first handshake. That's why our partners always move first.
ADC platform, Phase II-ready
- Science readiness
- 92
- BD fit
- 88
- Compliance screen
- 95
Surgical robotics platform
- Science readiness
- 89
- BD fit
- 84
- Compliance screen
- 97
AI-powered IVD panel
- Science readiness
- 90
- BD fit
- 86
- Compliance screen
- 93
300+ assets across all healthcare sectors by Q4 2027 · Partners preview every listing 30 days early.
Request the 10-company sample packFind your place in the story
Six Seats on the Bridge. One Is Yours.
Every audience has its own on-ramp to the platform. Take yours.
Global Healthcare Startups
Your breakthrough deserves a global stage.
MNC BD & Strategy Teams
Stop chasing leads. Start selecting deals.
VCs & Crossover Investors
AI-curated, compliance-clean, and a 30-day first look.
CROs, CDMOs & Ecosystem Partners
Become the execution engine of every platform deal.
Regulators & Policy Leaders
Shape the global framework — before it shapes you.
Alliances & Associations
Turn your member network into live deal flow.
Already in motion
Proof, Not Promises
The platform isn't a pitch. We're already convening the ecosystem and building relationships at the highest level.
Research Triangle Park · April 2026 · with SAPA-NC
Biotech Innovation & Investment Summit 2026
A flagship summit that convened 220+ biotech innovators, investors and industry leaders — headlined by a keynote from 2019 Nobel laureate Dr. Gregg L. Semenza.
Business development · Ongoing
Connections at Nobel Caliber
Through our events and network we've established business relationships across the ecosystem — including with the venture advancing a Nobel laureate's HIF science toward the clinic.
In good company
Sino-American Pharmaceutical Professionals Assoc. — NC
China Pharmaceutical Innovation, Shanghai
Global Healthcare Innovation Summit
AI Generative Mining
Uni-Pioneers BioMed
Who built the bridge
Three Founders. Three Disciplines. One Platform.
BridgeBio Global was founded by a clinician, a dealmaker, and an AI builder — the exact three lenses every cross-border healthcare deal has to pass through.
The Clinician
A physician-scientist who has taken therapies from bench to bedside — fluent in trial design, FDA and NMPA pathways, and the clinical bar every asset must clear.
Clinical & RegulatoryThe Dealmaker
A cross-border business leader who has structured licensing deals and partnerships between startups and global pharma — and knows what makes an MNC say yes.
Business & BDThe AI Builder
The architect of the Innovation Assets Database — building the scoring, matching and valuation engine that moves deals in days, not months.
AI & PlatformYour move
Your Seat at the Table Is Ready
Authentic urgency, not artificial scarcity: three founding seats, one summit, real deadlines.
Countdown to CPIC Founding Delegation · July 22–24
Days
Hours
Minutes
Seconds
Founding Partner
Only 3 founding slots remain- Complimentary Innovation Radar Enterprise access
- Every Radar listing, 30 days before the market
- Summit keynote-track speaking slot and exhibit booth
- Direct cross-border BD facilitation, deal to term sheet
Strategic Partner
- Full Innovation Radar access
- Summit exhibit booth and delegation priority
- Quarterly global market briefings
- Introductions across the global hub-city network
Network Member
- Radar teaser profiles and sample packs
- Summit attendance and community sessions
- Monthly cross-border deal digest
- Access to open delegation programs
The paradigm has shifted. The bridge is open.
An AI-driven paradigm is rewriting healthcare BD. BridgeBio Global built the bridge — for every region, every sector, every innovator who dares to go global.